Moving from IND submission to first patient enrollment requires more than regulatory approval — it takes strategic alignment across clinical, operational, and scientific teams. This article from inSeption Group explores how proactive planning and cross-functional readiness can help reduce delays and position programs for early clinical success.
How To Build Strategic Readiness For First-In-Human Studies

